Suchergebnisse

The Clorox Company CLX framed fiscal 2027 as a year of better execution but continued pressure. ERP comparisons and GOJO should lift reported growth, while value-seeking consumers, muted categories

Vertex Pharmaceuticals Incorporated VRTX raised its 2026 revenue outlook as cystic fibrosis growth and contributions from newer products accelerated.

Management framed 2026 as an execution year

Patterson-UTI Energy, Inc. PTEN shares have gained 20% in the past month as U.S. drilling activity, equipment utilization and service pricing improve. The advance follows a weaker 12-week stretch

Fortive Corporation FTV raised its 2026 adjusted earnings outlook after second-quarter earnings and revenues exceeded estimates as organic growth accelerated. Price, volume and productivity gains

The beverage industry is set for a busy earnings week as several leading companies prepare to report second-quarter 2026 results. Investors will closely monitor how consumer demand, pricing

Builders FirstSource, Inc. BLDR lowered its 2026 outlook as softer housing activity and competitive pricing weighed on earnings. The reset turns the construction slowdown into a more immediate issue

BrightSpring Health Services, Inc. BTSG exceeded second-quarter expectations and raised its 2026 outlook as pharmacy and provider operations expanded together. The results strengthened the case that

The stock market is roaring back as Wall Street continues to buy up beaten-down AI stocks and beyond. In almost the blink of an eye, the S&P 500 has charged to new all-time highs as Wall Street

Markets have remained choppy over the past few months as investors continue to shun technology and AI-related chip stocks amid growing concerns about the sector's long-term prospects. Despite that

Assurant (AIZ) came out with quarterly earnings of $6.41 per share, beating the Zacks Consensus Estimate of $5.16 per share. This compares to earnings of $5.56 per share a year ago. These figures

For the quarter ended June 2026, Assurant (AIZ) reported revenue of $3.46 billion, up 10.5% over the same period last year. EPS came in at $6.41, compared to $5.56 in the year-ago quarter.

The

Astera Labs, Inc. (ALAB) came out with quarterly earnings of $0.8 per share, beating the Zacks Consensus Estimate of $0.69 per share. This compares to earnings of $0.44 per share a year ago. These

Destination funds are a family of multi-asset mutual funds, managed by Brinker Capital. They hold a variety of asset classes and are managed using a multi-manager approach. Decisions regarding the

For most investors, how much a stock's price changes over time is important. This factor can impact your investment portfolio as well as help you compare investment results across sectors and

For most investors, how much a stock's price changes over time is important. This factor can impact your investment portfolio as well as help you compare investment results across sectors and

For most investors, how much a stock's price changes over time is important. This factor can impact your investment portfolio as well as help you compare investment results across sectors and

Here at Zacks, we offer our members many different opportunities to take full advantage of the stock market, as well as how to invest in ways that lead to long-term success.

The Zacks Premium

Here at Zacks, we offer our members many different opportunities to take full advantage of the stock market, as well as how to invest in ways that lead to long-term success.

The Zacks Premium